213 related articles for article (PubMed ID: 8990063)
1. A long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.
Negrotti A; Calzetti S
Mov Disord; 1997 Jan; 12(1):107-10. PubMed ID: 8990063
[TBL] [Abstract][Full Text] [Related]
2. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
Negrotti A; Calzetti S; Sasso E
Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
[TBL] [Abstract][Full Text] [Related]
3. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
Teive HA; Troiano AR; Germiniani FM; Werneck LC
Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
[TBL] [Abstract][Full Text] [Related]
4. Cinnarizine-induced parkinsonism: ten years later.
Martí-Massó JF; Poza JJ
Mov Disord; 1998 May; 13(3):453-6. PubMed ID: 9613736
[TBL] [Abstract][Full Text] [Related]
5. Movement disorders and depression due to flunarizine and cinnarizine.
Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
[TBL] [Abstract][Full Text] [Related]
6. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?
Calzetti S; Negrotti A
J Neurol Sci; 2023 Jan; 444():120526. PubMed ID: 36584558
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.
Capellà D; Laporte JR; Castel JM; Tristán C; Cos A; Morales-Olivas FJ
BMJ; 1988 Sep; 297(6650):722-3. PubMed ID: 3147743
[No Abstract] [Full Text] [Related]
8. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
Miguel R; Correia AS; Bugalho P
J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483
[TBL] [Abstract][Full Text] [Related]
9. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
[TBL] [Abstract][Full Text] [Related]
10. Flunarizine- and cinnarizine-induced extrapyramidal reactions.
Micheli F; Pardal MF; Gatto M; Torres M; Paradiso G; Parera IC; Giannaula R
Neurology; 1987 May; 37(5):881-4. PubMed ID: 3574697
[TBL] [Abstract][Full Text] [Related]
11. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
[TBL] [Abstract][Full Text] [Related]
12. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
Jhang KM; Huang JY; Nfor ON; Tung YC; Ku WY; Lee CT; Liaw YP
Eur J Clin Pharmacol; 2017 Jul; 73(7):911-916. PubMed ID: 28386684
[TBL] [Abstract][Full Text] [Related]
13. Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine.
Fabiani G; Pastro PC; Froehner C
Arq Neuropsiquiatr; 2004 Sep; 62(3B):784-8. PubMed ID: 15476069
[TBL] [Abstract][Full Text] [Related]
14. D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.
Brücke T; Wöber C; Podreka I; Wöber-Bingöl C; Asenbaum S; Aull S; Wenger S; Ilieva D; Harasko-van der Meer C; Wessely P
J Cereb Blood Flow Metab; 1995 May; 15(3):513-8. PubMed ID: 7714010
[TBL] [Abstract][Full Text] [Related]
15. [New forms of Parkinsonism in hospice care].
Baquero M; Domínguez-Sanz FJ; Burguera JA; Cruz Campos GA; Muñoz R
Rev Neurol; 1995; 23(123):964-8. PubMed ID: 8556606
[TBL] [Abstract][Full Text] [Related]
16. [Akathisia, parkinsonism and depression induced by cinnarizine: a case report].
Stucchi-Portocarrero S; Vega-Dienstmaier JM; Saavedra JE; Sagástegui A
Rev Neurol; 1999 May 1-15; 28(9):876-8. PubMed ID: 10390751
[TBL] [Abstract][Full Text] [Related]
17. [Parkinsonism due to the medication].
Louter M; Tromp SC
Ned Tijdschr Geneeskd; 2009; 153():A336. PubMed ID: 19900308
[TBL] [Abstract][Full Text] [Related]
18. [Parkinsonism, depression and akathisia induced by flunarizine, a calcium entry blockade--report of 31 cases].
Kuzuhara S; Kohara N; Ohkawa Y; Fuse S; Yamanouchi H
Rinsho Shinkeigaku; 1989 Jun; 29(6):681-6. PubMed ID: 2582681
[TBL] [Abstract][Full Text] [Related]
19. Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study.
Lin HL; Lin HC; Tseng YF; Chen SC; Hsu CY
Eur J Clin Pharmacol; 2017 Mar; 73(3):365-371. PubMed ID: 27986997
[TBL] [Abstract][Full Text] [Related]
20. [Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs].
Martí Massó JF; Poza JJ
Neurologia; 1996 Jan; 11(1):10-5. PubMed ID: 8714170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]